You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Bladder cancer

ADXBLADDER for detecting bladder cancer

  • Medtech innovation briefing
  • Reference number: MIB180
  • Published:  12 April 2019

Download (PDF)
  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Specialist commentator comments
  • Specialist commentators
  • Development of this briefing

Regulatory information

ADXBLADDER was CE marked as a self-certificated in vitro diagnostic on 10 October 2017.


Next page Equality considerations Previous page The technology
Back to top